TLDR Early treatment of PCOS is crucial for better health and quality of life.
Polycystic ovary syndrome (PCOS) is a prevalent endocrinopathy in women of reproductive age, characterized by hyperandrogenism, chronic anovulation, and polycystic ovaries. It leads to various symptoms and increases the risk of metabolic, cardiovascular, and reproductive disorders, significantly impacting psychological well-being and quality of life. Dermatological signs such as hirsutism, acne, and androgenetic alopecia are key indicators for diagnosis. Early treatment, involving hormonal and non-hormonal therapies, is crucial for improving patient outcomes, with dermatologists playing a vital role in the multidisciplinary management of PCOS.
8 citations
,
February 2010 in “Journal für Kardiologie (Krause & Pachernegg GmbH)” A new system helps better diagnose and treat female androgenization conditions like PCOS.
42 citations
,
July 2015 in “Journal of The American Academy of Dermatology” The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.
60 citations
,
October 2014 in “Journal of the American Academy of Dermatology” Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.
10 citations
,
January 2014 in “Endocrinology & metabolic syndrome” PCOS is a long-term condition that needs more research for better understanding and treatment.
9 citations
,
June 2014 in “European Journal of Obstetrics & Gynecology and Reproductive Biology” Blood AMH levels are higher in women with PCOS than in those with other similar conditions.
44 citations
,
September 2020 in “International Journal of Molecular Sciences” New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.
